delta sleep-inducing peptide and Lung Adenocarcinoma

delta sleep-inducing peptide has been researched along with Lung Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acencio, M; Antonângelo, L; Capelozzi, V; Fabro, A; Parra, E; Takagaki, T; Terra, R; Tuma, T; Vargas, F	1

Other Studies

1 other study(ies) available for delta sleep-inducing peptide and Lung Adenocarcinoma

Article	Year
Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy. Experimental biology and medicine (Maywood, N.J.), 2016, Volume: 241, Issue:11 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Biometry; Chemotherapy, Adjuvant; Delta Sleep-Inducing Peptide; Female; Humans; Immunohistochemistry; Inhibitor of Differentiation Protein 1; Inhibitor of Differentiation Proteins; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Proteins; Neovascularization, Pathologic; Prognosis	2016

Article

Year

Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy.

Experimental biology and medicine (Maywood, N.J.), 2016, Volume: 241, Issue:11

Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Biometry; Chemotherapy, Adjuvant; Delta Sleep-Inducing Peptide; Female; Humans; Immunohistochemistry; Inhibitor of Differentiation Protein 1; Inhibitor of Differentiation Proteins; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Proteins; Neovascularization, Pathologic; Prognosis

2016